SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Veglia F.))
 

Sökning: (WFRF:(Veglia F.)) > Subclinical atheros...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00008462naa a2201429 4500
001oai:gup.ub.gu.se/282972
003SwePub
008240910s2019 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:141456399
009oai:lup.lub.lu.se:95c10b9c-1e9f-44a3-bc04-d77fe96b5c78
024a https://gup.ub.gu.se/publication/2829722 URI
024a https://doi.org/10.1111/joim.129512 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1414563992 URI
024a https://lup.lub.lu.se/record/95c10b9c-1e9f-44a3-bc04-d77fe96b5c782 URI
040 a (SwePub)gud (SwePub)kid (SwePub)lu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Saliba-Gustafsson, P.u Karolinska Institute,Karolinska Institutet,Stanford University,Karolinska University Hospital4 aut
2451 0a Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy
264 c 2019-07-29
264 1b Wiley,c 2019
520 a Background Hyperlipidaemia is a major risk factor for cardiovascular disease, and atherosclerosis is the underlying cause of both myocardial infarction and stroke. We have previously shown that the Pro251 variant of perilipin-2 reduces plasma triglycerides and may therefore be beneficial to reduce atherosclerosis development. Objective We sought to delineate putative beneficial effects of the Pro251 variant of perlipin-2 on subclinical atherosclerosis and the mechanism by which it acts. Methods A pan-European cohort of high-risk individuals where carotid intima-media thickness has been assessed was adopted. Human primary monocyte-derived macrophages were prepared from whole blood from individuals recruited by perilipin-2 genotype or from buffy coats from the Karolinska University hospital blood central. Results The Pro251 variant of perilipin-2 is associated with decreased intima-media thickness at baseline and over 30 months of follow-up. Using human primary monocyte-derived macrophages from carriers of the beneficial Pro251 variant, we show that this variant increases autophagy activity, cholesterol efflux and a controlled inflammatory response. Through extensive mechanistic studies, we demonstrate that increase in autophagy activity is accompanied with an increase in liver-X-receptor (LXR) activity and that LXR and autophagy reciprocally activate each other in a feed-forward loop, regulated by CYP27A1 and 27OH-cholesterol. Conclusions For the first time, we show that perilipin-2 affects susceptibility to human atherosclerosis through activation of autophagy and stimulation of cholesterol efflux. We demonstrate that perilipin-2 modulates levels of the LXR ligand 27OH-cholesterol and initiates a feed-forward loop where LXR and autophagy reciprocally activate each other; the mechanism by which perilipin-2 exerts its beneficial effects on subclinical atherosclerosis.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a 27OH-cholesterol
653 a atherosclerosis
653 a autophagy
653 a liver-X-receptor
653 a PLIN2
653 a reverse cholesterol transport
653 a macrophage foam cells
653 a accumulation
653 a efflux
653 a identification
653 a stimulation
653 a metabolism
653 a receptors
653 a ser251pro
653 a protects
653 a General & Internal Medicine
700a Pedrelli, M.u Karolinska Institute,Karolinska Institutet4 aut
700a Gertow, K.u Karolinska Institute,Karolinska University Hospital4 aut
700a Werngren, O.u Karolinska Institute,Karolinska University Hospital4 aut
700a Janas, V.u Karolinska Institute,Karolinska University Hospital4 aut
700a Pourteymour, S.4 aut
700a Baldassarre, D.u University of Milan,Centro Cardiologico Monzino4 aut
700a Tremoli, E.u Centro Cardiologico Monzino,University of Milan4 aut
700a Veglia, F.u Centro Cardiologico Monzino4 aut
700a Rauramaa, R.u University of Eastern Finland4 aut
700a Smit, A. J.u University Medical Center Groningen4 aut
700a Giral, P.u Pitié-Salpêtrière University Hospital4 aut
700a Kurl, S.u University of Eastern Finland4 aut
700a Pirro, M.u University of Perugia4 aut
700a de Faire, U.u Karolinska Institute,Karolinska Institutet4 aut
700a Humphries, S. E.u Karolinska Institute,Karolinska Institutet,University College London,Karolinska University Hospital4 aut
700a Hamsten, A.u Karolinska Institute,Karolinska Institutet,Karolinska University Hospital4 aut
700a Gonçalves, I.u Lund University,Lunds universitet,Kardiovaskulär forskning - translationella studier,Forskargrupper vid Lunds universitet,Cardiovascular Research - Translational Studies,Lund University Research Groups4 aut0 (Swepub:lu)medf-igo
700a Orho-Melander, M.u Lund University,Lunds universitet,Diabetes - kardiovaskulär sjukdom,Forskargrupper vid Lunds universitet,Diabetes - Cardiovascular Disease,Lund University Research Groups4 aut0 (Swepub:lu)endo-mor
700a Franco-Cereceda, A.u Karolinska Institute,Karolinska Institutet,Karolinska University Hospital4 aut
700a Borén, Jan,d 1963u University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory,Sahlgrenska University Hospital4 aut0 (Swepub:gu)xborej
700a Eriksson, P.u Karolinska Institute,Karolinska Institutet,Karolinska University Hospital4 aut
700a Magne, J.u Karolinska Institute,Karolinska Institutet,St Jude Children´s Research Hospital, Memphis,Karolinska University Hospital4 aut
700a Parini, P.4 aut
700a Ehrenborg, E.4 aut
700a Sirtori, C. R.4 aut
700a Castelnuovo, S.4 aut
700a Amato, M.4 aut
700a Frigerio, B.4 aut
700a Ravani, A.4 aut
700a Sansaro, D.4 aut
700a Tedesco, C.4 aut
700a Bovis, F.4 aut
700a Discacciati, A.4 aut
700a Ahl, M.4 aut
700a Blomgren, G.4 aut
700a Eriksson, M. J.4 aut
700a Fahlstadius, P.4 aut
700a Heinonen, M.4 aut
700a Nilson, L.4 aut
700a Cooper, J.4 aut
700a Acharya, J.4 aut
700a Huttunen, K.4 aut
700a Rauramaa, E.4 aut
700a Pekkarinen, H.4 aut
700a Penttila, I. M.4 aut
700a Torronen, J.4 aut
700a van Gessel, A. I.4 aut
700a van Roon, A. M.4 aut
700a Teune, G. C.4 aut
700a Kuipers, W. D.4 aut
700a Bruin, M.4 aut
700a Nicolai, A.4 aut
700a Haarsma-Jorritsma, P.4 aut
700a Mulder, D. J.4 aut
700a Bilo, H. J. G.4 aut
700a Smeets, G. H.4 aut
700a Beaudeux, J. L.4 aut
700a Kahn, J. F.4 aut
700a Carreau, V.4 aut
700a Kontush, A.4 aut
700a Karppi, J.4 aut
700a Nurmi, T.4 aut
700a Nyyssonen, K.4 aut
700a Salonen, R.4 aut
700a Tuomainen, T. P.4 aut
700a Tuomainen, J.4 aut
700a Kauhanen, J.4 aut
700a Vaudo, G.4 aut
700a Alaeddin, A.4 aut
700a Siepi, D.4 aut
700a Lupattelli, G.4 aut
700a Schillaci, G.4 aut
710a Karolinska Instituteb Karolinska Institutet4 org
773t Journal of Internal Medicined : Wileyg 286:6, s. 660-675q 286:6<660-675x 0954-6820x 1365-2796
856u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/joim.12951
856u http://dx.doi.org/10.1111/joim.12951x freey FULLTEXT
8564 8u https://gup.ub.gu.se/publication/282972
8564 8u https://doi.org/10.1111/joim.12951
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:141456399
8564 8u https://lup.lub.lu.se/record/95c10b9c-1e9f-44a3-bc04-d77fe96b5c78

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy